Sign in

CIK 0001281895

  • Non-accelerated filer
  • Smaller reporting company

ROCKET PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-440-9100
Business address
350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
Former names
INOTEK PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$411,605
in 5 filings

Net −$411,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 48 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-02-25 Shah Gaurav President & CEO Exercise or conversion · Stock Option (Right to Buy) −290,000 90,925
2020-02-10 Schwartz Jonathan David Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −213,101 38,309
2020-02-10 Schwartz Jonathan David Chief Medical Officer Grant or award · Stock Option (Right to Buy) +7,000 7,000
2020-02-10 Patel Kinnari Chief Operating Officer Grant or award · Stock Option (Right to Buy) +15,000 15,000
2020-02-10 Militello John Grant or award · Stock Option (Right to Buy) +2,000 2,000
2020-02-10 Alam Kamran SVP - Finance & PFO Grant or award · Stock Option (Right to Buy) +3,000 3,000
2020-02-06 Shah Gaurav President & CEO Grant or award · Stock Option (Right to Buy) +383,306 383,306
2020-02-06 Schwartz Jonathan David Chief Medical Officer Grant or award · Stock Option (Right to Buy) +75,000 75,000
2020-02-06 Patel Kinnari Chief Operating Officer Grant or award · Stock Option (Right to Buy) +150,000 150,000
2020-02-06 Militello John Grant or award · Stock Option (Right to Buy) +20,000 20,000
2020-02-06 Alam Kamran SVP - Finance & PFO Grant or award · Stock Option (Right to Buy) +25,000 25,000
2019-12-10 RTW INVESTMENTS, LP Director Purchase +225,000 $22.25 $5.0M 17,282,324
2019-11-04 Alam Kamran SVP - Finance & PFO Grant or award · Stock Option (Right to Buy) +200,000 200,000
2019-09-02 Schwartz Jonathan David Chief Medical Officer Grant or award · Stock Option (Right to Buy) +30,000 30,000
2019-09-02 Patel Kinnari Chief Operating Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2019-09-02 Militello John Grant or award · Stock Option (Right to Buy) +10,000 10,000
2019-04-16 RTW INVESTMENTS, LP Director Purchase +550,005 $17.50 $9.6M 17,057,324
2019-03-05 Shah Gaurav Director Sale −25,000 $16.90 $423K 686,950
2019-03-04 Shah Gaurav Director Sale −24,900 $17.28 $430K 711,950
2019-03-01 Shah Gaurav Director Sale −25,000 $17.34 $434K 736,850

Page 25 of 27 · 538 trades